Bivalent biogenic amine reuptake inhibitors

Keith Fandrick, Xianqi Feng, Aaron Janowsky, Robert Johnson, John R. Cashman

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

A series of aryltropane-based bivalent ligands was prepared and investigated for binding potency and for their ability to inhibit reuptake of human dopamine, serotonin and norepinephrine transporters. The bivalent ligand 4, comprised of linking an aryltropane by an octamethylene spacer showed high efficacy for the human dopamine transporter and had a discrimination ratio of 130.

Original languageEnglish (US)
Pages (from-to)2151-2154
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume13
Issue number13
DOIs
StatePublished - Jul 7 2003

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Bivalent biogenic amine reuptake inhibitors'. Together they form a unique fingerprint.

  • Cite this